@article{Bloom_C-2021_26426,
title = {Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19:a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK},
author = {Bloom, C. and Drake, T. and Docherty, A. and Lipworth, B. and Johnston, S. and Nguyen-Van-Tam, J. and Carson, G. and Dunning, J. and Harrison, E. and Baillie, J. and Semple, M. and Cullinan, P. and Openshaw, P.},
month = {mar},
year = {2021},
abstract = {Background: Studies of patients admitted to hospital with COVID-19 have found varying mortality outcomes associated with underlying respiratory conditions and inhaled corticosteroid use. Using data from a national, multicentre, prospective cohort, we aimed to characterise people with COVID-19 admitted to hospital with underlying respiratory disease, assess the level of care received, measure in-hospital mortality, and examine the effect of inhaled corticosteroid use.},
journal = {The Lancet Respiratory Medicine},
publisher = {Elsevier},
url = {https://doi.org/10.1016/S2213-2600(21)00013-8},
}
